Clinical Trial

Safety of the Sonablate HIFU System for the Ablation of Incompetent Veins of the Periphery

Study acronym: HIFIVE
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is to learn if the Sonablate High Intensity Focused Ultrasound device can be safely used to treat patients with Chronic Venous Incompetence (CVI) including those with venous malformations of the periphery meaning legs, abdomen, chest or back. Examples of CVI are varicose veins, vascular congestion, venous ulcer, venous clusters, venous anomalies, mixed malformation, Klippel-Trenaunay Syndrome, CLOVES, Syndrome, Blue Rubber bleb Nevus Syndrome. HIFU is a non-invasive treatment as opposed to current treatment options which include incisions, needle penetration, wire insertions or catheter insertions.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-10-10.
Status change: Recruiting → Active, Not Recruiting 2026-02-17
Trial Details
NCT Number NCT06642051
Lead Sponsor Sonablate
Collaborators: Vascular Care CT, PLLC, Vascular Breakthroughs, LLC
Conditions Chronic Venous Insufficiency, CVI, Venous Malformations, Venous Leg Ulcers, Klippel-Trenaunay Syndrome, CLOVES Syndrome, Blue Rubber Bleb Nevus Syndrome
Enrollment 30 participants
Start Date 2024-09-11
Primary Completion 2027-09 (estimated)
Study Completion 2028-02 (estimated)
Updated on ClinicalTrials.gov 2026-02-19